Futura Medical
MED3000 on course for OTC approval in Europe and USFutura Medical
FDA green lights MED3000 for OTC approvalFutura Medical
AGM statement confirms MED3000 filings on trackFutura Medical
Nearing the critical point in Erectile DysfunctionFutura Medical
MED3000: more detail on FM57 resultsFutura Medical
Encouraging FY19 results and MED3000 updateFutura Medical
MED3000 European regulatory pathway is clearerFutura Medical
Fund raise of £3.25m, at 8p a share, confirmed at EGMFutura Medical
Remarkable data from pivotal trial opens new possibilitiesFutura Medical
Are these unprecedented results a major opportunity?